Bibliography
- MILLER DH, KHAN OA, SHEREMATA WA: A controlled trial of natalizumab for relapsing multiple sclerosis. N. Engl. J. Med. (2003) 348:15-23.
- POLMAN CH, O’CONNOR PW, HAVRDOVA E et al.: A randomised, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N. Engl. J. Med. (2006) 354:899-910.
- LANGER-GOULD A, ATLAS SW, GREEN AJ, BOLLEN AW, PELLETIER D: Progressive multifocal leukoencephalopathy in a patients treated with natalizumab. N. Engl. J. Med. (2005) 353:375-381.
- KLEINSCHMIDT-DEMASTERS BK, TYLER KL: Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon-β1a for multiple sclerosis. N. Engl. J. Med. (2005) 353:369-374.
- RUDICK RA, STUART WH. CALABRESI PA et al.: Natalizumab plus interferon-β1a for relapsing multiple sclerosis. N. Engl. J. Med. (2006) 354:911-923.
- VAN ASSCHE G, VAN RANST M, SCIOT R et al.: Progressive multifocal leukoencephalopathy after natalizumab therapy in Crohn’s disease. N. Engl. J. Med. (2005) 353:362-368.
- YOUSRY TA, MAJOR EO. RYSCHKEWITSCH C et al.: Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy. N. Engl. J. Med. (2006) 354:924-933.
- ROPPER AH: Selective treatment of multiple sclerosis. N. Engl. J. Med. (2006) 354:965-966.
- CHAUDHURI A: Lessons for clinical trials from natalizumab in multiple sclerosis. Br. Med. J. (2006) 332:416-419.
Website
- http://www.emedicine.com/emerg/ topic321.htm An informative article on MS.